![]() |
市場調查報告書
商品編碼
1625265
血庫設備市場至2030年的預測:按產品、採集方法、應用、最終用戶和地區的全球分析Blood Banking Equipment Market Forecasts to 2030 - Global Analysis by Product, Mode of Collection, Application, End User and By Geography |
根據 Stratistics MRC 的資料,2024年全球血庫設備市場規模為 163.221億美元,預計到2030年將達到 239.507億美元,預測期內年複合成長率為 6.6%。
血庫設備包括用於血液採集、處理、儲存和輸血的專用設備和技術,以確保血液製品的安全性和完整性。這包括自動血液處理設備、血漿分離器、離心機、儲存冰箱和冷凍庫、採血袋、血型和交叉配血系統。設備還包括輸血加溫器、運輸容器和監測工具,用於監測輸血和儲存期間的溫度和狀況。為了提供有效的輸血和捐血服務,這些技術對於維持血液製品品質、避免污染並確保臨床實踐中捐贈者和接受者的兼容性非常重要。
根據世界衛生組織(WHO)的資料,2018年全球共進行了 1.185億次捐血。
慢性病和手術盛行率上升
慢性病和手術盛行率的上升是血庫設備需求的主要驅動力。隨著癌症、糖尿病和心血管疾病等慢性疾病的增加,定期輸血和相關治療的需求也增加。同樣,包括器官移植和創傷護理在內的手術的激增需要有效的血液儲存和管理。這一趨勢推動對先進血庫設備的需求,以確保醫療程序所需的血液製品的穩定和安全供應。
初期投資成本高
血庫設備產業的初始投資成本高昂可能會阻礙創新技術的採用,特別是在小型或資金緊張的醫療機構。這種成本障礙限制了現代設備的使用,並降低了營運的安全性和效率。它還可能阻礙現金流,推遲血庫服務的成長,並阻礙對基本維護和升級的投資,所有這些都將阻礙整體市場的擴張。
技術進步
技術進步透過提高血液採集、儲存和輸血的效率、準確性和安全性來推動市場發展。自動血型、病原體檢測和冷凍系統等創新可確保更高的血液品質並減少人為錯誤。此外,先進的監控系統和資料分析整合增強了庫存管理和可追溯性。這些發展推動市場發展,因為它們不僅簡化了業務,而且滿足了日益成長的輸血需求,有助於改善患者的治療效果和改善醫療保健服務。
供不應求
血庫設備市場的血液供不應求可能導致治療延遲、死亡率增加以及手術和緊急情況下的併發症。醫院可能面臨關鍵血液製品的短缺,影響病患照護。這種短缺也給血庫帶來了負擔,增加了營運成本和對緊急捐血的依賴,擾亂了醫療保健系統,並增加了對先進血液儲存和管理設備的需求,限制了市場的擴張。
COVID-19 大流行對血庫設備市場產生了重大影響,由於封鎖和社交疏遠措施,供應鏈中斷並減少了捐血活動。然而,對恢復期血漿的需求不斷增加,人們對醫療基礎設施的認知不斷提高,刺激了對先進血庫技術的投資,對疫情期間和疫情後的市場動態產生了各種影響。
血庫產業預計將成為預測期內最大的細分市場
由於慢性病的流行、外科手術數量的增加和緊急醫療需求的增加,導致對離心機、血液儲存冰箱和自動血液分析儀等先進設備的依賴增加,血庫行業將在預測期內繼續成長。全球最大的此外,對血液處理安全性和準確性的日益關注推動創新並推動市場成長。血庫在塑造該產業的發展軌跡方面發揮關鍵作用。
預計自動採血領域在預測期間內年複合成長率最高
由於自動化血液採集系統簡化了血液採集過程、減少了人工錯誤並提高了血液成分分離的準確性,因此預計自動化血液採集領域在預測期內將出現最高的年複合成長率。自動化可以加快處理速度,有助於滿足醫療保健和緊急情況下對血液不斷成長的需求。此外,它還支援遵守嚴格的品質標準並降低營運成本。資料分析的整合進一步最佳化庫存管理和可追溯性,推動已開發市場和新興市場的採用並推動市場成長。
由於慢性病盛行率上升、老年人口增加以及輸血需求增加等因素,預計北美在預測期內將佔據最大的市場佔有率。此外,自動血液成分分離系統和血庫資訊系統等血庫設備的技術進步進一步推動市場成長。此外,嚴格的血液安全和品質保證監管標準推動該地區採用先進的血庫設備。
由於慢性病的流行和需要輸血的老年人數量的增加,預計亞太地區在預測期內的年複合成長率最高。鼓勵自願捐血的政府計劃和擴大醫院基礎設施都做出了重大貢獻。此外,血液處理、檢測和儲存方面的技術發展提高操作安全性和效率,進一步推動產業向前發展。
According to Stratistics MRC, the Global Blood Banking Equipment Market is accounted for $16,322.1 million in 2024 and is expected to reach $23,950.7 million by 2030 growing at a CAGR of 6.6% during the forecast period. Blood banking equipment includes specialized instruments and technologies used in blood collection, processing, storage, and transfusion to assure the safety and integrity of blood products. This comprises automated blood processing equipment, plasma separators, centrifuges, storage refrigerators and freezers, blood collection bags, and blood typing and crossmatching systems. Blood warmers, transit containers, and monitoring tools to keep tabs on temperature and conditions during transfusion and storage are also included in the equipment. In order to provide effective blood transfusion and donation services, these technologies are essential for preserving the quality of blood products, avoiding contamination, and guaranteeing donor and recipient compatibility in clinical settings.
According to the World Health Organization, 118.5 million blood donations were collected globally in 2018.
Rising Prevalence of Chronic Diseases and Surgeries
The rising prevalence of chronic diseases and surgeries significantly drives the demand for blood banking equipment. As chronic conditions like cancer, diabetes, and cardiovascular diseases increase, the need for regular blood transfusions and related treatments grows. Similarly, the surge in surgeries, including organ transplants and trauma care, necessitates efficient blood storage and management. This trend propels the demand for advanced blood banking equipment to ensure a steady and safe supply of blood products for medical procedures.
High Initial Investment Costs
Adoption of innovative technologies may be impeded by high initial investment costs in the blood banking equipment industry, particularly for smaller or more financially strapped healthcare facilities. This cost barrier restricts access to contemporary equipment, which lowers operating safety and efficiency. It may also hinder cash flow, postpone the growth of blood bank services, and deter investment in essential maintenance or upgrades, all of which would hinder market expansion as a whole.
Technological Advancements
Technological advancements are driving the market by improving efficiency, accuracy, and safety in blood collection, storage, and transfusion. Innovations such as automated blood typing, pathogen detection, and refrigeration systems ensure higher blood quality and reduce human errors. Additionally, the integration of advanced monitoring systems and data analytics enhances inventory management and traceability. These developments not only streamline operations but also meet the growing demand for blood transfusions, contributing to better patient outcomes and healthcare services, thus it propels market expansion.
Blood Supply Shortages
Blood supply shortages in the Blood Banking Equipment market can lead to delayed medical treatments, increased mortality rates, and complications during surgeries or emergencies. Hospitals may face a shortage of critical blood products, affecting patient care. This shortage also strains blood banks, leading to higher operational costs and reliance on emergency donations, disrupting healthcare systems and increasing the need for advanced blood storage and management equipment, thus it limits the market expansion.
The COVID-19 pandemic significantly impacted the Blood Banking Equipment market, disrupting supply chains and reducing blood donation drives due to lockdowns and social distancing measures. However, increased demand for convalescent plasma and heightened awareness of healthcare infrastructure spurred investments in advanced blood banking technologies, creating a mixed effect on market dynamics during and post-pandemic.
The blood banks segment is expected to be the largest during the forecast period
The blood banks segment is expected to be the largest during the forecast period due to increasing prevalence of chronic diseases, rising surgical procedures, and emergency care needs amplify the reliance on advanced equipment such as centrifuges, blood storage refrigerators, and automated blood analyzers. Additionally, the growing focus on safety and precision in blood handling fosters innovation, boosting market growth. Blood banks play a pivotal role in shaping this industry's trajectory.
The automated blood collection segment is expected to have the highest CAGR during the forecast period
The automated blood collection segment is expected to have the highest CAGR during the forecast period as these systems streamline collection processes, reducing manual errors and improving the precision of blood component separation. Automation enables faster processing, meeting rising blood demand in healthcare and emergency settings. Additionally, it supports compliance with stringent quality standards and reduces operational costs. The integration of data analytics further optimizes inventory management and traceability, driving adoption in developed and emerging markets, thereby boosting market growth.
North America is projected to hold the largest market share during the forecast period because of factors like increasing prevalence of chronic diseases, rising geriatric population, and growing demand for blood transfusions. Additionally, technological advancements in blood banking equipment, such as automated blood component separation systems and blood bank information systems, are further propelling market growth. Furthermore, stringent regulatory standards for blood safety and quality assurance are driving the adoption of advanced blood banking equipment in the region.
Asia Pacific is projected to witness the highest CAGR over the forecast period because chronic illnesses are becoming more common and the number of elderly people needing transfusions is increasing. Government programs encouraging voluntary blood donation and the expansion of hospital infrastructure both make substantial contributions. Moreover, technological developments in blood processing, testing, and storage improve operating safety and efficiency, drives the industry even more.
Key players in the market
Some of the key players in Blood Banking Equipment market include Medtronic, BD Medical, Boston Scientific Corporation, Argon Medical Devices, Novo Nordisk, Terumo Corporation, NIPRO Medical, B. Braun, Cardinal Health, Hi-Tech Medicare Devices, Abbott Laboratories, Beckman Coulter, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., Cerus Corporation, CSL Behring LLC and Fresenius Kabi AG.
In October 2024, Abbott announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options.
In September 2024, Abbott and Seed Global Health announced the launch of a new partnership to train and support highly skilled health workers to help advance maternal and child health in Malawi.
In August 2024, Abbott announced the expansion of its Pure Bliss by Similac line of organic and European-made infant formulas that give parents a variety of products to meet specific formula preferences.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.